BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3057485)

  • 1. [Arfazetin in the treatment of diabetes mellitus].
    Korotkova VD; Perelygina AA; Trumpe TE; Sokolov SIa; Lobanova AM
    Probl Endokrinol (Mosk); 1988; 34(4):25-8. PubMed ID: 3057485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of food and drug plant factors in the combined treatment of patients with type-II diabetes mellitus].
    Korotkova VD; Perelygina AA; Antsiferov MB; Lobanova AM; Trumpe TE
    Probl Endokrinol (Mosk); 1989; 35(6):24-9. PubMed ID: 2560185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
    Hu M; Wu H; Chao C
    Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 5. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
    Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes in the elderly, Part II. Finding the balance for drug therapy.
    Cirone N; Schwartz N
    Nursing; 1996 Mar; 26(3):40-5; quiz 46-7. PubMed ID: 8700471
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
    Ferrannini E
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acarbose, an unduly neglected antidiabetic drug].
    Iványi J; Gyimesi A
    Orv Hetil; 1996 Dec; 137(49):2737-41. PubMed ID: 9679608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
    Abdel-Zaher AO; Ahmed IT; El-Koussi AD
    Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposing a new design for self-monitoring blood glucose logs.
    Raz I; Zary R; Ben Dayan E
    Diabetes Metab Res Rev; 2016 Jan; 32(1):60-2. PubMed ID: 26751604
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid restoration of normoglycaemia using intravenous insulin boluses.
    Dunnett JM; Steemson J; Sear JW; Turner RC; Holman RR
    Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nutritional and metabolic status and dietetic evaluation in institutionalized elderly patients with non-insulin-dependent diabetes mellitus].
    Casimiro C; García de Lorenzo A; Usán L;
    Nutr Hosp; 2001; 16(3):104-11. PubMed ID: 11475679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus type II: when convert to insulin?].
    Bianda TL; Spinas GA
    Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus.
    Waheed A; Miana GA; Ahmad SI
    Pak J Pharm Sci; 2006 Oct; 19(4):322-5. PubMed ID: 17105712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Kempf P; Laimer M; Stettler C
    Ther Umsch; 2017; 74(8):417-422. PubMed ID: 29461149
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical characteristics of patients with type-2 diabetes mellitus].
    Gendeleka GF; Lakiza VV; Perstnev AI
    Lik Sprava; 1996; (5-6):109-13. PubMed ID: 9377371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ; Jobe LJ; Martin R
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISPAD Clinical Practice Consensus Guidelines 2014. Exercise in children and adolescents with diabetes.
    Robertson K; Riddell MC; Guinhouya BC; Adolfsson P; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():203-23. PubMed ID: 25182315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.